Benjamin Tausheck, PA
Physician Assistant · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 1 carrier
- Offices
- 2
Offices
2 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Plans that list them
14 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Benjamin Tausheck’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
Medicaid work
$10,770 in 2023
Medicaid paid $10,770 for 191 billed services this clinician did in 2023, up to 79 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 95 | $10,299 |
| Telehealth transmission, per minute, professional services bill separately | 96 | $472 |
| 2023 | 191 | 2 | 79 | $10,770 |
| 2022 | 3,218 | 5 | 113 | $200,653 |
| 2021 | 249 | 5 | 58 | $3,874 |
See the largest Medicaid services in earlier years
2022
| Short return visit (20+ min) | 1,346 | $148,027 |
| Return visit (30+ min) | 168 | $26,896 |
| New patient visit (60+ min) | 31 | $9,381 |
| Telehealth transmission, per minute, professional services bill separately | 1,643 | $9,334 |
| Psychiatric diagnostic evaluation with medical services | 30 | $7,016 |
2021
| Psychiatric diagnostic evaluation with medical services | 42 | $2,139 |
| Short return visit (20+ min) | 44 | $1,269 |
| Long return visit (40+ min) | 19 | $265 |
| Telehealth transmission, per minute, professional services bill separately | 131 | $201 |
| Return visit (30+ min) | 13 | $0 |
Drugs they prescribed that Part D paid
$40,921
Pharmacies billed $40,921 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 398) in 2024. At or below the middle of the specialty; the typical physician assistant clinician is at 1%.
338 generic and 60 brand-name prescriptions · $40,921 in drug cost · 11 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Hydroxyzine | 17 | $1,371 | $81 |
| Lurasidone | 31 | $1,307 | $42 |
| Duloxetine | 44 | $1,238 | $28 |
| Divalproex | 20 | $709 | $35 |
| Quetiapine | 15 | $136 | $9 |
See all 10 drugs
| Hydroxyzine | 17 | $1,371 | $81 |
| Lurasidone | 31 | $1,307 | $42 |
| Duloxetine | 44 | $1,238 | $28 |
| Divalproex | 20 | $709 | $35 |
| Quetiapine | 15 | $136 | $9 |
| Sertraline | 22 | $100 | $5 |
| Levothyroxine | 16 | $86 | $5 |
| Lithium Carbonate | 16 | $75 | $5 |
| Clonazepam | 12 | $42 | $3 |
| Alprazolam | 19 | $19 | $1 |
Year by year
| 2024 | 398 | 16 | 0% (0) | 15% | $40,921 |
| 2023 | 1,004 | 67 | 0% (0) | 14% | $304,930 |
| 2022 | 1,563 | 80 | 0% (0) | 16% | $409,105 |
| 2021 | 51 | 26 | 0% (0) | None | $10,633 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 30 drugs
| Vraylar | 19 | $46,886 | $2,468 |
| Ritalin La | 11 | $23,816 | $2,165 |
| Latuda | 26 | $23,164 | $891 |
| Lurasidone | 34 | $19,848 | $584 |
| Aripiprazole | 31 | $11,178 | $361 |
| Focalin Xr | 13 | $6,685 | $514 |
| Olanzapine | 36 | $5,483 | $152 |
| Vyvanse | 13 | $5,054 | $389 |
| Modafinil | 12 | $4,829 | $402 |
| Pregabalin | 41 | $3,590 | $88 |
| Duloxetine | 51 | $2,903 | $57 |
| Divalproex | 36 | $2,762 | $77 |
| Quetiapine | 53 | $2,365 | $45 |
| Bupropion Xl | 23 | $1,882 | $82 |
| Prazosin | 46 | $1,820 | $40 |
| Fluoxetine | 16 | $1,140 | $71 |
| Venlafaxine Hcl Er | 18 | $1,113 | $62 |
| Buspirone | 18 | $804 | $45 |
| Sertraline | 61 | $800 | $13 |
| Zolpidem Tartrate Er | 11 | $778 | $71 |
| Lamotrigine | 33 | $582 | $18 |
| Escitalopram | 13 | $531 | $41 |
| Propranolol | 20 | $488 | $24 |
| Paroxetine | 20 | $482 | $24 |
| Trazodone | 20 | $417 | $21 |
| Clonazepam | 28 | $407 | $15 |
| Lorazepam | 14 | $312 | $22 |
| Diazepam | 19 | $295 | $16 |
| Lithium Carbonate | 28 | $266 | $10 |
| Alprazolam | 24 | $163 | $7 |
2022: 34 drugs
| Vraylar | 47 | $92,863 | $1,976 |
| Latuda | 44 | $91,459 | $2,079 |
| Vyvanse | 36 | $16,743 | $465 |
| Aripiprazole | 55 | $14,661 | $267 |
| Modafinil | 30 | $13,113 | $437 |
| Olanzapine | 100 | $7,159 | $72 |
| Pregabalin | 79 | $4,928 | $62 |
| Prazosin | 63 | $3,052 | $48 |
| Bupropion Xl | 39 | $2,824 | $72 |
| Duloxetine | 33 | $2,403 | $73 |
| Divalproex | 64 | $2,303 | $36 |
| Quetiapine | 20 | $1,790 | $89 |
| Escitalopram | 34 | $1,357 | $40 |
| Bupropion Hcl Sr | 21 | $1,110 | $53 |
| Alprazolam Xr | 11 | $825 | $75 |
| Buspirone | 34 | $757 | $22 |
| Gabapentin | 21 | $751 | $36 |
| Lamotrigine | 58 | $743 | $13 |
| Oxcarbazepine | 16 | $665 | $42 |
| Trazodone | 39 | $664 | $17 |
| Clonazepam | 84 | $649 | $8 |
| Methylphenidate | 17 | $615 | $36 |
| Sertraline | 58 | $575 | $10 |
| Mirtazapine | 30 | $560 | $19 |
| Propranolol | 31 | $550 | $18 |
| Lorazepam | 67 | $527 | $8 |
| Lithium Carbonate | 44 | $480 | $11 |
| Venlafaxine Hcl Er | 23 | $420 | $18 |
| Paroxetine | 23 | $309 | $13 |
| Levothyroxine | 20 | $222 | $11 |
| Citalopram Hbr | 14 | $201 | $14 |
| Zolpidem | 26 | $200 | $8 |
| Diazepam | 13 | $199 | $15 |
| Fluoxetine | 18 | $89 | $5 |
Money from drug and device companies
$71 in 2025
| 2025 | 1 | 1 | None | $71 |
| 2024 | 10 | 62 | None | $1,357 |
| 2023 | 13 | 84 | None | $2,005 |
| 2022 | 5 | 6 | None | $152 |
| 2021 | 2 | 7 | None | $179 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Neurocrine BioSciences | Ingrezza | $71 | 1 payment
|
See the published payment
| Neurocrine BioSciences | Meals · 2025-11-05 | Ingrezza | $71 |
See earlier years (2024, 2023, 2022, 2021)
2024: $1,357
| Abbvie | Vraylar | $385 | 22 payments
|
| Neurocrine Biosciences | Ingrezza | $268 | 6 payments
|
| Alkermes | Aristada | $152 | 7 payments
|
| Lundbeck | Abilify Asimtufii | $137 | 9 payments
|
| Teva Pharmaceuticals USA | Austedo Xr | $109 | 5 payments
|
| Axsome Therapeutics | Auvelity | $93 | 4 payments
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $90 | 4 payments
|
| Otsuka America Pharmaceutical | Abilify Maintena | $53 | 2 payments
|
| Tris Pharma | Dyanavel Xr | $45 | 2 payments
|
| Indivior | Perseris | $26 | 1 payment
|
2023: $2,005
| Abbvie | Vraylar | $459 | 23 payments
|
| Alkermes | Aristada | $308 | 16 payments
|
| Janssen Pharmaceuticals | Spravato | $297 | 10 payments
|
| Indivior | Perseris | $194 | 8 payments
|
| Teva Pharmaceuticals USA | Austedo Xr | $176 | 7 payments
|
| Axsome Therapeutics | Sunosi | $175 | 4 payments
|
| Iti | Caplyta | $129 | 5 payments
|
| Otsuka America Pharmaceutical | Rexulti | $80 | 3 payments
|
| Neurocrine Biosciences | Ingrezza | $80 | 3 payments
|
| Lundbeck | Abilify Asimtufii | $53 | 2 payments
|
| ACADIA Pharmaceuticals | Nuplazid | $22 | 1 payment
|
| Tris Pharma | Dyanavel Xr | $20 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $14 | 1 payment
|
2022: $152
| Indivior | Perseris | $50 | 2 payments
|
| Janssen Pharmaceuticals | Invega Sustenna | $35 | 1 payment
|
| Sunovion Pharmaceuticals | Latuda | $24 | 1 payment
|
| Otsuka America Pharmaceutical | Rexulti | $21 | 1 payment
|
| Abbvie | Vraylar | $21 | 1 payment
|
2021: $179
| Otsuka America Pharmaceutical | Rexulti | $145 | 2 payments
|
| Sunovion Pharmaceuticals | Latuda | $34 | 5 payments
|
Professional record
- NPI
- 1285203422
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 1285203422
- Taxonomy
- Physician assistant, medical (363AM0700X)
- Mailing address
- Po Box 276950, Sacramento, CA, 95827
- NPI first listed
- 2021-06-22
- NPI last updated
- 2025-01-07
- NPI record certified
- 2025-01-07
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1742 Oregon St, Redding, CA, 96001 · 615 Ocean St, Santa Cruz, CA, 95060